Jonatan D. Lindh

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

Fumihiko Takeuchi, Ralph McGinnis, Stéphane Bourgeois et al. · PLoS Genetics · 2009 · 640 citations · Full text

Medicine, Molecular Genetics, Pharmacology +13

The largest prospective warfarin-treated cohort supports genetic forecasting

Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh et al. · Blood · 2008 · 552 citations · Full text

Life Sciences, Genetics, Pharmacology +4

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

Petra Lenzini, Mia Wadelius, Stephen Kimmel et al. · Clinical Pharmacology & Therapeutics · 2010 · 214 citations

Medicine, Pharmacology, Pharmacotherapy +16

Vitamin D₃ supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study

Peter Bergman, Anna-Carin Norlin, Susanne Hansen et al. · BMJ Open · 2012 · 189 citations · Full text

Veterinary Medicine, Infectious Diseases, Nutritional Sciences +16

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age

Anna‐Karin Hamberg, Mia Wadelius, Jonatan D. Lindh et al. · Clinical Pharmacology & Therapeutics · 2010 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +17